Cargando…

Irritable bowel syndrome-like symptoms associated with endoscopic activity predict ulcerative colitis relapse in patients with clinical remission

Detalles Bibliográficos
Autores principales:	Fukuba, Nobuhiko, Ishihara, Shunji, Kawashima, Kousaku, Mishima, Yoshiyuki, Oshima, Naoki, Kinoshita, Yoshikazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association for the Study of Intestinal Diseases 2017
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683988/ https://www.ncbi.nlm.nih.gov/pubmed/29142525 http://dx.doi.org/10.5217/ir.2017.15.4.543

Ejemplares similares

Fecal calprotectin level correlated with both endoscopic severity and disease extent in ulcerative colitis
por: Kawashima, Kousaku, et al.
Publicado: (2016)

Capabilities of fecal calprotectin and blood biomarkers as surrogate endoscopic markers according to ulcerative colitis disease type
por: Sonoyama, Hiroki, et al.
Publicado: (2019)

Comorbid irritable bowel syndrome symptoms and headache have greater association with anxiety than depression: Annual health check-up survey results
por: Kawashima, Kousaku, et al.
Publicado: (2020)

Decreased Frequency of Intestinal Regulatory CD5(+) B Cells in Colonic Inflammation
por: Mishima, Yoshiyuki, et al.
Publicado: (2016)

Proton pump inhibitor is a risk factor for recurrence of common bile duct stones after endoscopic sphincterotomy – propensity score matching analysis
por: Fukuba, Nobuhiko, et al.
Publicado: (2017)

Therapeutic Efficacy of pH-Dependent Release Formulation of Mesalazine on Active Ulcerative Colitis Resistant to Time-Dependent Release Formulation: Analysis of Fecal Calprotectin Concentration
por: Kawashima, Kousaku, et al.
Publicado: (2014)

Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome
por: Mishima, Yoshiyuki, et al.
Publicado: (2020)

Long-lasting renal dysfunction following tacrolimus induction therapy in ulcerative colitis patients
por: Cha, Na, et al.
Publicado: (2022)

Differential gene expression analysis of dasatinib-induced colitis in a patient with chronic myeloid leukemia followed for 3 years: a case report
por: Oshima, Naoki, et al.
Publicado: (2021)

Enteric Microbiota-Mediated Serotonergic Signaling in Pathogenesis of Irritable Bowel Syndrome
por: Mishima, Yoshiyuki, et al.
Publicado: (2021)

Induction of mucosal healing by intensive granulocyte/monocyte adsorptive apheresis (GMA) without use of corticosteroids in patients with ulcerative colitis: long-term remission maintenance after induction by GMA and efficacy of GMA re-treatment upon relapse
por: Fukuchi, Takumi, et al.
Publicado: (2022)

Usefulness of computed tomography with air insufflation of the stomach prior to percutaneous endoscopic gastrostomy procedure
por: Kawashima, Kousaku, et al.
Publicado: (2016)

Interobserver variation in the endoscopic diagnosis of gastroduodenal ulcer scars: implications for clinical management of NSAIDs users
por: Amano, Yuji, et al.
Publicado: (2011)

Successful Endoscopic Management of Non-Healing Perforated Duodenal Ulcer with Polyglycolic Acid Sheet and Fibrin Glue
por: Mishiro, Tsuyoshi, et al.
Publicado: (2016)

Eosinophilic Granulomatosis with Polyangiitis Initially Diagnosed as Eosinophilic Gastroenteritis
por: Itawaki, Ayako, et al.
Publicado: (2019)

The Simultaneous Onset of Pancreatitis and Colitis as Immune-related Adverse Events in a Patient Receiving Nivolumab Treatment for Renal Cell Carcinoma
por: Yazaki, Tomotaka, et al.
Publicado: (2021)

Increased Colonic Epithelial Permeability and Mucosal Eosinophilia in Ulcerative Colitis in Remission Compared With Irritable Bowel Syndrome and Health
por: Katinios, Georgios, et al.
Publicado: (2020)

Mucosal Biofilms Are an Endoscopic Feature of Irritable Bowel Syndrome and Ulcerative Colitis
por: Baumgartner, Maximilian, et al.
Publicado: (2021)

Endoscopic fenestration treatment for pneumatosis cystoides intestinalis in patient with recurrent colonic intussusception
por: Takahashi, Yusuke, et al.
Publicado: (2023)

Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls
por: Lundgren, D., et al.
Publicado: (2016)

Heterotopic Gastric Mucosa in Middle Esophagus Complicated with Esophageal Ulcers
por: Kishimoto, Kenichi, et al.
Publicado: (2022)

Intermittent Purpura Development Associated with Leukocytoclastic Vasculitis Induced by Infliximab for Crohn's Disease
por: Kishimoto, Kenichi, et al.
Publicado: (2020)

Histologic Inflammation can Predict Future Clinical Relapse in Ulcerative Colitis Patients in Endoscopic Remission
por: George, Lauren A, et al.
Publicado: (2023)

Successful Transanal Removal of a Rectal Foreign Body by Abdominal Compression under Endoscopic and X-Ray Fluoroscopic Observation: A Case Report
por: Mikami, Hironobu, et al.
Publicado: (2016)

Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota
por: Noor, Samah O, et al.
Publicado: (2010)

Decreased Plasma Histidine Level Predicts Risk of Relapse in Patients with Ulcerative Colitis in Remission
por: Hisamatsu, Tadakazu, et al.
Publicado: (2015)

Juvenile social defeat stress exposure favors in later onset of irritable bowel syndrome-like symptoms in male mice
por: Matsumoto, Kenjiro, et al.
Publicado: (2021)

Differential diagnosis of ulcerative colitis with increased diarrhea; collagenous colitis or irritable bowel syndrome? A case report
por: Haraikawa, Mayuko, et al.
Publicado: (2022)

A186 ASSOCIATION OF ULCERATIVE COLITIS BOWEL URGENCY IMPROVEMENT WITH CLINICAL RESPONSE AND REMISSION
por: Clemow, D B, et al.
Publicado: (2023)

Correlation of Biomarkers with Endoscopic Score: Ulcerative Colitis Endoscopic Index of Severity (UCEIS) in Patients with Ulcerative Colitis in Remission
por: Pop, Corina Silvia, et al.
Publicado: (2020)

Prostaglandin E-Major Urinary Metabolite Predicts Relapse in Patients With Ulcerative Colitis in Clinical Remission
por: Ishida, Natsuki, et al.
Publicado: (2020)

Analysis of Endoscopic Evaluation Reliability for Ulcerative Colitis in Histological Remission
por: Kanazawa, Mimari, et al.
Publicado: (2021)

Prevalence and risk factors of bowel symptoms in Korean patients with ulcerative colitis in endoscopic remission: a retrospective study
por: Nam, Kwangwoo, et al.
Publicado: (2021)

Endoscopic score vs. fecal biomarkers for predicting relapse in patients with ulcerative colitis after clinical remission and mucosal healing
por: Yamamoto, Takayuki, et al.
Publicado: (2018)

Fecal calprotectin is a useful marker to diagnose ulcerative colitis from irritable bowel syndrome
por: Kalantari, Hamid, et al.
Publicado: (2015)

Therapeutic Potential of Proanthocyanidins in Ulcerative Colitis in Remission
por: Głąbska, Dominika, et al.
Publicado: (2020)

Transcriptional Signatures That Define Ulcerative Colitis in Remission
por: Fenton, Christopher G, et al.
Publicado: (2020)

Relapsing Polychondritis and Ulcerative Colitis
por: Almadi, Majid A., et al.
Publicado: (2010)

Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis
por: Matsuoka, Katsuyoshi, et al.
Publicado: (2018)

Clinical Efficacy of Probiotic Therapy on Bowel-Related Symptoms in Patients with Ulcerative Colitis during Endoscopic Remission: An Observational Study
por: Lee, Jin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qinbdohlqolph6pup5eq8hkg3a